Author

M.Lia Palomba

Observed names: M L. Palomba, M Palomba, M. L Palomba, M. L. Palomba, ML Palomba

Institution: Memorial Sloan Kettering Cancer Center

Observed institution: Memorial Sloan Kettering Cancer Center

OpenAlex ID: A5046147356

S262: the Cobalt-lym Study of Ctx130: a Phase 1 Dose Escalation Study of Cd70-targeted Allogeneic Crispr-cas9–engineered Car T Cells in Patients With Relapsed/refractory (r/r) T-cell Malignancies

2022 · S. P. Iyer, R. A. Sica, et al. · HemaSphere · 46

Efficacy of Pirtobrutinib, a Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Relapsed / Refractory Waldenström Macroglobulinemia: Results from the Phase 1/2 BRUIN Study

2022 · M.Lia Palomba, Manish R. Patel, et al. · Blood · 31

Report of consensus panel 2 from the 11th international workshop on Waldenström's macroglobulinemia on the management of relapsed or refractory WM patients

2023 · S D'Sa, JV Matous, et al. · Seminars in Hematology · 14

The COBALT-LYM study of CTX130: a phase 1 dose escalation study of CD70-targeted allogeneic CRISPR-Cas9–engineered CAR T cells in patients with relapsed/refractory (R/R) T-cell malignancies

2022 · DR Zain, SP Iyer, et al. · European Journal of Cancer · 8

Brentuximab Vedotin Combined with Chemotherapy in Newly Diagnosed, Early-Stage, Unfavorable-Risk Hodgkin Lymphoma: Extended Follow-up with Evaluation of Baseline Metabolic Tumor Volume and PET2

2022 · Robert Stuver, Laure Michaud, et al. · Blood · 7

Report of consensus panel 7 from the 11th international workshop on Waldenström macroglobulinemia on priorities for novel clinical trials

2023 · CS Tam, P Kapoor, et al. · Seminars in Hematology · 4

Inflammatory Biomarker Clusters Are Predictive of Response and Toxicity in Large B-Cell Lymphoma Treated with CD19 CAR-T Cell Therapy

2022 · Sandeep Raj, Miguel-Angel Perales, et al. · Blood · 1

Predictors and Implications of Renal Injury in Large Cell Lymphoma Patients Receiving CD19 CAR T Cell Therapy

2022 · Alexander P. Boardman, Victoria Gutgarts, et al. · Blood · 1

717 | Leptomeningeal Disease Is Associated With Myc Chromosomal Alterations and Worse Overall Survival Among Secondary Cns Lymphoma Patients Treated With Salvage Radiotherapy

2025 · G. Cederquist, K. Tringale, et al. · Hematological Oncology

451 | Myc Alterations Confer Worse Local Control in Patients Undergoing Bridging Radiotherapy Prior to Car‐t

2025 · R. R. Patel, B. Fregonese, et al. · Hematological Oncology

452 | Bridging Radiotherapy Does Not Increase Risk of Car T‐cell Associated Toxicity

2025 · R. R. Patel, A. Tward, et al. · Hematological Oncology

182 | Genomic Testing in Patients With Large Cell and Follicular Lymphoma Treated With T‐cell Engagers Bi‐specific Antibodies and Correlation With Treatment Response

2025 · R. Tavarozzi, A. Rivas Delgado, et al. · Hematological Oncology

Characterization of a Large Cohort of Patients with Nodal Marginal Zone Lymphoma Shows Prolonged Survival, Time-to-Treatment, and Time-to-Transformation

2022 · Robert Stuver, Esther Drill, et al. · Blood

A phase II study of N-acetylcysteine in cancer patients with severe COVID-19: clinical outcomes and biological correlates

2022 · William Johnson, Hannah Kalvin, et al. · Research Square

P1101: Pirtobrutinib, a Highly Selective, Non-covalent (reversible) Btk Inhibitor in Previously Treated Mantle Cell Lymphoma: Updated Results From the Phase 1/2 Bruin Study

2022 · T. A. Eyre, M. L. Wang, et al. · HemaSphere

Works count: 15

Citation count: 112

H-index: 5

I10-index: 3